Mimpara

cinacalcet hydrochloride · Amgen Europe B.V.

Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Mimpara, covering 2013-11-14 to 2024-06-06. Get the full timeline:

Most recent: EMA Authorised: Mimpara (cinacalcet hydrochloride) — Amgen Europe B.V.